Independence Capital Asset Partners’s Biogen BIIB Stock Holding History

Independence Capital Asset Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-24,215	Closed	-$10.2M	–	37
2015 Q1	$10.2M	Buy	+24,215	New	+$9.54M	1.59%	31
2013 Q3	–	Sell	-39,837	Closed	-$8.57M	–	89
2013 Q2	$8.57M	Buy	+39,837	New	+$8.51M	1.49%	29

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Independence Capital Asset Partners's BIIB Position: Q2 2015 in Review

Independence Capital Asset Partners sold out of Biogen (BIIB) in Q2 2015, closing a stake of 24,215 shares — an estimated $10.2M sold.

Independence Capital Asset Partners first reported a position in BIIB in Q2 2013 and held it in 2 quarters. The position peaked at $10.2M in Q1 2015. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

Independence Capital Asset Partners reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
Independence Capital Asset Partners sold 24,215 Biogen shares in Q2 2015, an estimated $10.2M.
Independence Capital Asset Partners first reported a position in Biogen in Q2 2013 and held it in 2 quarters.
Independence Capital Asset Partners's Biogen position peaked at $10.2M in Q1 2015.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on Independence Capital Asset Partners's 13F filing for Q2 2015, filed 13 Aug 2015.